STARMED America
Tracked across 1 events · 6 articles · First seen Jun 30, 2026 · Last active Jul 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: STARMED America received FDA 510(k) clearance for its thyroid nodule ablation system, making it the first and only company globally with such a specific indication. This significantly enhances its market position and potential for growth in the United States and other countries.
Jun 30, 2026 · 6 articles
100
United States — Food and Drug Administration granted clearance STARMED AmericaSTARMED Receives FDA Clearance
50
STARMED America developed electrodeSTARMED Receives FDA Clearance
ERGEN INTELLIGENCE
Track STARMED America live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard